Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
39.7M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
4.75M
-
Shares change
-
+4.49M
-
Total reported value, excl. options
-
$25.9M
-
Value change
-
+$24.4M
-
Number of buys
-
14
-
Price
-
$5.60
Significant Holders of AEON Biopharma, Inc. - Class A Common Stock (AEON) as of Q3 2023
15 filings reported holding AEON - AEON Biopharma, Inc. - Class A Common Stock as of Q3 2023.
AEON Biopharma, Inc. - Class A Common Stock (AEON) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.75M shares
of 39.7M outstanding shares and own 11.96% of the company stock.
Largest 10 shareholders include Atalaya Capital Management LP (3.68M shares), Ikarian Capital, LLC (258K shares), BlackRock Inc. (242K shares), VANGUARD GROUP INC (194K shares), GEODE CAPITAL MANAGEMENT, LLC (171K shares), Formidable Asset Management, LLC (64.3K shares), BOOTHBAY FUND MANAGEMENT, LLC (55.1K shares), NORTHERN TRUST CORP (32.5K shares), GOLDMAN SACHS GROUP INC (24.3K shares), and BANK OF AMERICA CORP /DE/ (23.4K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.